Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Hypofractionated Radiotherapy”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableActive Not RecruitingNCT05994300
What this trial is testing

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

Who this might be right for
Cervical NeoplasmAdaptive RadiotherapyRadiotherapy; Adverse Effect
Peking Union Medical College Hospital 30
Not applicableLooking for participantsNCT05705921
What this trial is testing

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

Who this might be right for
Prostate Cancer
The Netherlands Cancer Institute 484
Not applicableActive Not RecruitingNCT03827616
What this trial is testing

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms
Tatarstan Cancer Center 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07527520
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

Who this might be right for
Rectal CancerModerately Hypofractionated RadiotherapySerplulimab+1 more
Fudan University 165
Not applicableLooking for participantsNCT07020780
What this trial is testing

5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics

Who this might be right for
Breast Cancer
IRCCS San Raffaele 458
Not applicableLooking for participantsNCT05665920
What this trial is testing

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Who this might be right for
Malignant Breast Neoplasm
Instituto Brasileiro de Controle do Cancer 36
Not applicableLooking for participantsNCT06496256
What this trial is testing

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

Who this might be right for
Prostate Cancer
Palette Life Sciences, Inc. 84
Not applicableActive Not RecruitingNCT04262609
What this trial is testing

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

Who this might be right for
Faecal IncontinenceProstate Cancer
Consorci Sanitari de Terrassa 200
Not applicableLooking for participantsNCT04610372
What this trial is testing

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Who this might be right for
Oligometastatic Prostate Cancer
British Columbia Cancer Agency 168
Not applicableLooking for participantsNCT07343531
What this trial is testing

Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer

Who this might be right for
Cervical Carcinoma Stage IIICervical Carcinoma Stage IIBCervical Carcinoma Stage II
Ain Shams University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06389422
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06599827
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Who this might be right for
Rectal Cancer
Shanghai Zhongshan Hospital 54
Not applicableActive Not RecruitingNCT02307058
What this trial is testing

Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy

Who this might be right for
Prostate Cancer
University of Miami 164
Not applicableStudy completedNCT02361515
What this trial is testing

Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid

Who this might be right for
Prostatic Adenocarcinoma
Hospices Civils de Lyon 96
Not applicableActive Not RecruitingNCT02384733
What this trial is testing

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Who this might be right for
LymphedemaFibrosis
Danish Breast Cancer Cooperative Group 2,963
Not applicableLooking for participantsNCT05786742
What this trial is testing

Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.

Who this might be right for
Prostate CancerRadiotherapy Side EffectHypofractionation+3 more
CHU de Quebec-Universite Laval 205
Not applicableLooking for participantsNCT07116213
What this trial is testing

Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CancerHypofractionated DoseRadiotherapy, Adjuvant+2 more
Xiaorong Hou 20
Testing effectiveness (Phase 2)Study completedNCT03660449
What this trial is testing

Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 58
Not applicableLooking for participantsNCT07135661
What this trial is testing

Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy

Who this might be right for
Breast CancerProton Therapy
Shanghai Proton and Heavy Ion Center 312
Load More Results